ATP5MFP5

Across TCGA pan-cancer cohorts, ATP5MFP5 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of ATP5MFP5’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where ATP5MFP5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ATP5MFP5 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

COAD, UCEC, and LUAD are the cancer types where ATP5MFP5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ATP5MFP5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+1.021	<.001	6	view →
UCEC	All	All	+0.737	<.001	6	view →
LUAD	Female	All	+0.251	.002	5	view →
LUSC	All	II,III,IV	+0.207	.003	5	view →
BRCA	Female	II,III,IV	+0.087	.025	3	view →
HNSC	Male	All	+0.210	.018	2	view →
KICH	All	IV	+0.252	.026	1	view →
THCA	All	All	−0.155	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

ATP5MFP5–COAD

Open the COAD breakdown →